Literature DB >> 29407890

Selective inhibition of endothelial NF-κB signaling attenuates chronic intermittent hypoxia-induced atherosclerosis in mice.

Dongmei Song1, Guoqiang Fang2, Sun-Zhong Mao2, Xiaobing Ye2, Gang Liu2, Edmund J Miller2, Harly Greenberg2, Shu Fang Liu3.   

Abstract

BACKGROUND AND AIMS: Chronic intermittent hypoxia (CIH) exposure causes atherosclerosis, although the underlying mechanisms are poorly understood. This study defines the role of endothelial intrinsic NF-κB signaling in the atherogenic response to CIH.
METHODS: We created ApoE-ECI-κBmt mice that are deficient in the apolipoprotein E gene (ApoE-/-) and overexpress an I-κBα mutant (I-κBmt) selectively in endothelial cells. ApoE-/- and ApoE-ECI-κBmt mice were fed a normal chow diet (NCD) or high cholesterol diet (HCD) and exposed to sham or CIH, and atherosclerotic lesions were quantified.
RESULTS: CIH exposure activated NF-κB in aortas, and induced the expression of endothelial-specific and NF-κB-dependent genes, E-selectin and vascular cell adhesion molecule (VCAM)-1, in the aortas and hearts. Endothelial I-κBmt overexpression in ApoE-ECI-κBmt mice significantly inhibited CIH-induced NF-κB activity, and suppressed E-selectin and VCAM-1 expressions, confirming endothelial NF-κB inhibition in ApoE-ECI-κBmt mice. ApoE-/- mice, on NCD, developed mild atherosclerotic lesions spontaneously, and developed advanced and larger areas of atherosclerotic plaques when exposed to CIH. ApoE-/- mice also developed advanced atherosclerotic lesions when fed an HCD alone. The HCD-induced atherosclerotic plaques became more advanced, and plaque area was doubled in mice exposed to HCD + CIH. Endothelial I-κBmt overexpression in ApoE-ECI-κBmt mice attenuated spontaneously developed atherosclerotic lesions, abrogated CIH-induced atherosclerosis and mitigated CIH-mediated facilitation of HCD-induced atherosclerosis.
CONCLUSIONS: These results suggest that endothelial intrinsic NF-kB signaling may play a pivotal role in CIH-induced atherosclerosis.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Cardiovascular risk factor; Endothelial; Intermittent hypoxia; Nuclear factor kappa B; Obstructive sleep apnea

Mesh:

Substances:

Year:  2018        PMID: 29407890     DOI: 10.1016/j.atherosclerosis.2018.01.027

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  18 in total

Review 1.  Targeting Mechanosensitive Transcription Factors in Atherosclerosis.

Authors:  Niu Niu; Suowen Xu; Yanni Xu; Peter J Little; Zheng-Gen Jin
Journal:  Trends Pharmacol Sci       Date:  2019-02-28       Impact factor: 14.819

2.  Analysis of cardiovascular disease-related NF-κB-regulated genes and microRNAs in TNFα-treated primary mouse vascular endothelial cells.

Authors:  Hui Zhu; Yun Li; Mao-Xian Wang; Ju-Hong Wang; Wen-Xin Du; Fei Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2019 Oct.       Impact factor: 3.066

3.  Obstructive Sleep Apnea and Systemic Hypertension: Gut Dysbiosis as the Mediator?

Authors:  Saif Mashaqi; David Gozal
Journal:  J Clin Sleep Med       Date:  2019-10-15       Impact factor: 4.062

Review 4.  Mechanisms of cardiovascular disease in obstructive sleep apnoea.

Authors:  Silke Ryan
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

5.  Circ_0065149 Alleviates Oxidized Low-Density Lipoprotein-Induced Apoptosis and Inflammation in Atherosclerosis by Targeting miR-330-5p.

Authors:  Dan Li; Wen Jin; Li Sun; Jiawei Wu; Hao Hu; Likun Ma
Journal:  Front Genet       Date:  2021-02-02       Impact factor: 4.599

Review 6.  The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.

Authors:  Jan Korbecki; Klaudyna Kojder; Patrycja Kapczuk; Patrycja Kupnicka; Barbara Gawrońska-Szklarz; Izabela Gutowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

Review 7.  The Endothelium as a Target for Anti-Atherogenic Therapy: A Focus on the Epigenetic Enzymes EZH2 and SIRT1.

Authors:  Jolien Fledderus; Byambasuren Vanchin; Marianne G Rots; Guido Krenning
Journal:  J Pers Med       Date:  2021-02-05

8.  Feprazone Prevents Free Fatty Acid (FFA)-Induced Endothelial Inflammation by Mitigating the Activation of the TLR4/MyD88/NF-κB Pathway.

Authors:  Min Song; Liukun Meng; Xiaoxi Liu; Yan Yang
Journal:  ACS Omega       Date:  2021-02-09

9.  Mirabegron Ameliorated Atherosclerosis of ApoE-/- Mice in Chronic Intermittent Hypoxia but Not in Normoxia.

Authors:  Yue Wang; Yue Wang; Hong-Feng Jiang; Hai-Ming Dang; Meng-Ru Liu; Xin-Yan Liu; Yang Yu; Jiang Xie; Xiao-Jun Zhan; Hui-Na Zhang; Xiao-Fan Wu
Journal:  Cardiovasc Drugs Ther       Date:  2021-06-21       Impact factor: 3.947

10.  Integrating systematic biological and proteomics strategies to explore the pharmacological mechanism of danshen yin modified on atherosclerosis.

Authors:  Kailin Yang; Liuting Zeng; Anqi Ge; Xiaoping Pan; Tingting Bao; Zhiyong Long; Qiaozhen Tong; Mengxia Yuan; Xiaofei Zhu; Jinwen Ge; Zhengde Huang
Journal:  J Cell Mol Med       Date:  2020-11-02       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.